Concepts (78)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Non-alcoholic Fatty Liver Disease | 12 | 2022 | 212 | 1.870 |
Why?
|
| Liver Cirrhosis | 7 | 2022 | 300 | 1.510 |
Why?
|
| Liver Transplantation | 4 | 2022 | 1271 | 0.980 |
Why?
|
| Platelet Count | 2 | 2022 | 92 | 0.820 |
Why?
|
| Clinical Enzyme Tests | 1 | 2017 | 7 | 0.630 |
Why?
|
| Hepatitis | 1 | 2017 | 35 | 0.610 |
Why?
|
| Elasticity Imaging Techniques | 3 | 2022 | 59 | 0.420 |
Why?
|
| Aspartate Aminotransferases | 3 | 2022 | 73 | 0.400 |
Why?
|
| Biopsy | 3 | 2022 | 1163 | 0.300 |
Why?
|
| Obesity | 3 | 2019 | 964 | 0.290 |
Why?
|
| Severity of Illness Index | 4 | 2022 | 1802 | 0.290 |
Why?
|
| Metabolic Syndrome | 2 | 2017 | 142 | 0.270 |
Why?
|
| Biomarkers | 3 | 2022 | 1718 | 0.260 |
Why?
|
| Alanine Transaminase | 3 | 2018 | 73 | 0.230 |
Why?
|
| Child | 8 | 2022 | 6928 | 0.230 |
Why?
|
| Prevalence | 4 | 2019 | 1239 | 0.200 |
Why?
|
| ROC Curve | 1 | 2022 | 752 | 0.180 |
Why?
|
| Acyltransferases | 1 | 2019 | 41 | 0.180 |
Why?
|
| United States | 5 | 2019 | 6681 | 0.170 |
Why?
|
| Liver | 3 | 2021 | 1230 | 0.160 |
Why?
|
| Thinness | 1 | 2018 | 43 | 0.160 |
Why?
|
| Reproducibility of Results | 3 | 2022 | 2706 | 0.160 |
Why?
|
| Insulin Resistance | 2 | 2018 | 377 | 0.160 |
Why?
|
| Humans | 15 | 2022 | 86678 | 0.150 |
Why?
|
| Sterol Esterase | 1 | 2016 | 6 | 0.140 |
Why?
|
| Retrospective Studies | 2 | 2022 | 8496 | 0.140 |
Why?
|
| Nutrition Surveys | 1 | 2017 | 114 | 0.140 |
Why?
|
| Hypertension, Portal | 1 | 2016 | 47 | 0.140 |
Why?
|
| Hepatitis C | 1 | 2017 | 210 | 0.130 |
Why?
|
| Adolescent | 7 | 2021 | 8984 | 0.120 |
Why?
|
| Membrane Proteins | 1 | 2019 | 1196 | 0.110 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 1673 | 0.110 |
Why?
|
| Risk Factors | 3 | 2017 | 5420 | 0.110 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2016 | 386 | 0.110 |
Why?
|
| Male | 7 | 2021 | 40988 | 0.100 |
Why?
|
| Middle Aged | 4 | 2017 | 25040 | 0.100 |
Why?
|
| Liver Neoplasms | 1 | 2016 | 738 | 0.090 |
Why?
|
| Female | 6 | 2018 | 44550 | 0.090 |
Why?
|
| Adult | 4 | 2022 | 25659 | 0.090 |
Why?
|
| Diabetes Mellitus | 1 | 2017 | 806 | 0.080 |
Why?
|
| Treatment Outcome | 1 | 2017 | 7998 | 0.060 |
Why?
|
| Age Factors | 2 | 2018 | 1852 | 0.050 |
Why?
|
| Aged | 1 | 2017 | 18423 | 0.050 |
Why?
|
| Acylation | 1 | 2019 | 38 | 0.040 |
Why?
|
| Diet Therapy | 1 | 2018 | 20 | 0.040 |
Why?
|
| Vitamin E | 1 | 2018 | 35 | 0.040 |
Why?
|
| Keratin-18 | 1 | 2018 | 3 | 0.040 |
Why?
|
| Body Composition | 1 | 2018 | 68 | 0.040 |
Why?
|
| Lipoproteins, HDL | 1 | 2018 | 96 | 0.040 |
Why?
|
| Hypertriglyceridemia | 1 | 2018 | 67 | 0.040 |
Why?
|
| Triglycerides | 1 | 2018 | 232 | 0.040 |
Why?
|
| Health Surveys | 1 | 2018 | 239 | 0.040 |
Why?
|
| Hepatitis, Autoimmune | 1 | 2016 | 19 | 0.040 |
Why?
|
| Liver Cirrhosis, Biliary | 1 | 2016 | 29 | 0.040 |
Why?
|
| Hepatitis B, Chronic | 1 | 2016 | 32 | 0.040 |
Why?
|
| Cholestasis | 1 | 2016 | 47 | 0.040 |
Why?
|
| Metformin | 1 | 2018 | 128 | 0.040 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2016 | 52 | 0.040 |
Why?
|
| Italy | 1 | 2016 | 106 | 0.030 |
Why?
|
| End Stage Liver Disease | 1 | 2016 | 62 | 0.030 |
Why?
|
| Bariatric Surgery | 1 | 2018 | 194 | 0.030 |
Why?
|
| Hepatitis C, Chronic | 1 | 2016 | 126 | 0.030 |
Why?
|
| Disease Progression | 1 | 2019 | 1532 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2018 | 770 | 0.030 |
Why?
|
| Young Adult | 2 | 2016 | 5980 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 861 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 860 | 0.030 |
Why?
|
| Reoperation | 1 | 2016 | 597 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2016 | 695 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2016 | 816 | 0.030 |
Why?
|
| Graft Survival | 1 | 2016 | 885 | 0.030 |
Why?
|
| Logistic Models | 1 | 2016 | 1188 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 1621 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2021 | 4214 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2016 | 1807 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2016 | 3613 | 0.020 |
Why?
|
| Mice | 1 | 2019 | 11356 | 0.020 |
Why?
|
| Animals | 1 | 2019 | 26590 | 0.010 |
Why?
|